Details of the Drug-Related molecule(s) Expression Atlas
General Information of Drug (ID: DMLIG3X)
Drug Name | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
3,5-DIBROMOTYROSINE; 2-amino-3-(3,5-dibromo-4-hydroxyphenyl)propanoic acid; 537-24-6; 3,5-Dibromo-tyrosine; NSC210786; 3,5-Dibromo-DL-tyrosine; Bromotiren; CHEMBL1253341; CHEBI:80912; L-Tyrosine,5-dibromo-; Tyrosine,5-dibromo-, L-; Dibromotirina; Biotiren; NSC-210786; EINECS 208-661-9; Tyrosine,5-dibromo-; .beta.-(3,5-Dibromo-4-hydroxyphenyl)alanine; ACMC-209hco; AC1L1W1Q; SCHEMBL145218; CTK7I4423; MolPort-002-887-590; NSC97935; ZX-AN012875; NSC39452; ALBB-014135; NSC-97935; NSC-39452; BDBM50326563; AKOS005109959; MS-3024
|
|||||||||||||||||||
Indication |
|
|||||||||||||||||||
Cross-matching ID | ||||||||||||||||||||
Molecule(s) Related to This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs
|
||||||||||||||||||||||||||
Molecule Expression Atlas in Normal Tissue of Major ADME-related organs | ||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas between Disease Section and Healthy Individual Tissue | ||||||||||||||||||||||||